We have identified a tumor suppressor role of MG53 and its negative regulation of RAC1 signaling, and then we further try to demonstrate whether the anti-tumor effect of MG53 is mediated through RAC1-MAPK signaling. Here, TRIM72 is linked to neoplasm.